Publicação
The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver Disease
| Resumo: | Abstract Background: Metabolic-associated fatty liver disease (MAFLD) is an increasingly prevalent cause of chronic liver disease. In 2020, the FibroScan-AST (FAST) score was internationally validated as a new tool able to identify patients with steatohepatitis who benefit the most from further therapies, based on liver transient elastography (LTE) findings and serum levels of aspartate aminotransferase (AST). We aimed to identify, in MAFLD patients, which metabolic features may predict a higher FAST score. Methods: Retrospective study of consecutive patients with MAFLD submitted to LTE for two consecutive years. Patients without an AST sample collected within 6 months of the LTE were excluded. FAST score was calculated, stratifying the patient’s risk as low (<0.35), medium (0.35-0.67), or high (>0.67). Results: The sample included 117 patients, 53.0% of the female gender, with a mean age of 53 years. On multivariate analysis, patients with type 2 diabetes (T2DM) (p < 0.001), dyslipidemia (p = 0.046), and smoking habits (p = 0.037) presented with significantly higher FAST score values. Furthermore, diabetic patients did not only present significantly higher FAST scores but were also more frequently assigned to the high-risk group according to FAST score criteria (OR = 9.2; 95% CI = 1.8-45.5; p = 0.007). Conclusions: Calculating the FAST score, patients with T2DM presented a significantly higher risk of having significant fibrosis and steatohepatitis. Physicians may rely on this validated instrument to more easily identify which patients with T2DM and MAFLD benefit the most from a specialized follow-up. |
|---|---|
| Autores principais: | Silva,Vítor Macedo |
| Outros Autores: | Freitas,Marta; Xavier,Sofia; Carvalho,Pedro Boal; Magalhães,Joana; Marinho,Carla; Cotte,José |
| Assunto: | Metabolic-associated fatty liver disease Liver transient elastography Hepatology |
| Ano: | 2023 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Fundação para a Ciência e Tecnologia |
| Idioma: | inglês |
| Origem: | SciELO Portugal |
Registos relacionados
article Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease
por: Andrade,Patrícia
Publicado em: (2017)
por: Andrade,Patrícia
Publicado em: (2017)
school Prevalence and risk factors for fatty liver post liver transplantation : a systematic review and meta analysis
por: Silva, Ana Carolina Morais da
Publicado em: (2022)
por: Silva, Ana Carolina Morais da
Publicado em: (2022)
assignment Acute fatty liver of pregnancy: case report
por: Vilela,Fernanda
Publicado em: (2017)
por: Vilela,Fernanda
Publicado em: (2017)
article Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: challenges and opportunities
por: Silva, Barbara Sofia Marques da
Publicado em: (2025)
por: Silva, Barbara Sofia Marques da
Publicado em: (2025)
article Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease
por: Gaspar,Rui
Publicado em: (2024)
por: Gaspar,Rui
Publicado em: (2024)
article Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease
por: Machado, Mariana Verdelho
Publicado em: (2021)
por: Machado, Mariana Verdelho
Publicado em: (2021)
article Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease
por: Machado, Mariana
Publicado em: (2021)
por: Machado, Mariana
Publicado em: (2021)
article Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
por: Grattagliano, Ignazio
Publicado em: (2019)
por: Grattagliano, Ignazio
Publicado em: (2019)
article Prevalence and risk factors of fatty liver in Portuguese adults
por: Leitão, Jorge
Publicado em: (2020)
por: Leitão, Jorge
Publicado em: (2020)
article An Extreme Case of Liver Adenomatosis
por: Chálim Rebelo, Carolina
Publicado em: (2022)
por: Chálim Rebelo, Carolina
Publicado em: (2022)
assignment Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*)
por: Costa,Rita Quelhas da
Publicado em: (2022)
por: Costa,Rita Quelhas da
Publicado em: (2022)
article European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
por: Lazarus, Jeffrey V.
Publicado em: (2021)
por: Lazarus, Jeffrey V.
Publicado em: (2021)
article Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, M
Publicado em: (2020)
por: Borges-Canha, M
Publicado em: (2020)
article Post liver transplantation delirium assessment using the CAM-ICU-7 scale
por: Cardoso, Filipe S.
Publicado em: (2023)
por: Cardoso, Filipe S.
Publicado em: (2023)
article Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312∗); [Síndrome de Dorfman-Chanarin: uma causa rara de doença hepática gorda dismetabólica associada a homozigotia da mutação nonsense c.934C>T (p.R312∗)]
por: da Costa, RQ
Publicado em: (2022)
por: da Costa, RQ
Publicado em: (2022)
article Prevalence and risk factors of fatty liver in Portuguese adults
por: Leitão, Jorge
Publicado em: (2020)
por: Leitão, Jorge
Publicado em: (2020)
article How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound
por: Carvalhana, S.
Publicado em: (2013)
por: Carvalhana, S.
Publicado em: (2013)
article Transient elastography: should XL probe be used in all overweight patients?
por: Arieira, Cátia
Publicado em: (2019)
por: Arieira, Cátia
Publicado em: (2019)
article Será uma refeição ligeira fator de erro na avaliação da dureza hepática por elastografia hepática transitória? Um estudo prospetivo
por: Caetano, Ana Célia
Publicado em: (2014)
por: Caetano, Ana Célia
Publicado em: (2014)
article Non-alcoholic fatty liver disease: management in primary health care
por: Campos, Dina
Publicado em: (2025)
por: Campos, Dina
Publicado em: (2025)
article Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?
por: Machado, Mariana Verdelho
Publicado em: (2020)
por: Machado, Mariana Verdelho
Publicado em: (2020)
assignment Fatty Liver and Autoimmune Hepatitis: Two Forms of Liver Involvement in Lipodystrophies
por: Ribeiro,Andreia
Publicado em: (2019)
por: Ribeiro,Andreia
Publicado em: (2019)
school Development of specialized multicellular 3D-Organotypic models to evaluate pathogenic mechanisms in non-alcoholic fatty liver disease (NAFLD)
por: Baptista, Catarina Borges
Publicado em: (2024)
por: Baptista, Catarina Borges
Publicado em: (2024)
article What is the role of the new index relative fat mass (RFM) in the assessment of nonalcoholic fatty liver disease (NAFLD)?
por: Machado, M.V.
Publicado em: (2019)
por: Machado, M.V.
Publicado em: (2019)
article Endocrine disruptor DDE associated with a high-fat diet enhances the impairment of liver fatty acid composition in rats
por: Rodríguez-Alcalá, Luis M.
Publicado em: (2015)
por: Rodríguez-Alcalá, Luis M.
Publicado em: (2015)
school The role of RIPK3 in the crosstalk between hepatocytes and macrophages in metabolic-dysfunction associated steatotic liver disease
por: Alves, Mariana Isabel Francisco
Publicado em: (2023)
por: Alves, Mariana Isabel Francisco
Publicado em: (2023)
article Effect of selenium supplementation on polyunsaturated fatty acids in rat
por: Crespo, A.M.V.
Publicado em: (2011)
por: Crespo, A.M.V.
Publicado em: (2011)
article Non-Alcoholic Fatty Liver Disease: Literature Review: Fígado Gordo Não Alcoólico: Revisão da Literatura
por: Matos, Luís Costa
Publicado em: (2017)
por: Matos, Luís Costa
Publicado em: (2017)
school “A Healthy Liver Will Always Deliver” : Development of a Comic to Raise Awareness About Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Metabolic Disorders
por: Alemany i Pagès, Mireia
Publicado em: (2021)
por: Alemany i Pagès, Mireia
Publicado em: (2021)
article An international multidisciplinary consensus statement on MAFLD and the risk of CVD
por: Zhou, Xiao-Dong
Publicado em: (2023)
por: Zhou, Xiao-Dong
Publicado em: (2023)
school Inter-organ crosstalk in the pathogenesis of metabolic dysfunction associated steatotic liver disease
por: Ferreira, Nídia Mafalda Teixeira
Publicado em: (2024)
por: Ferreira, Nídia Mafalda Teixeira
Publicado em: (2024)
school Treatment options and combined therapies for metabolic associated fatty liver disease
por: Abreu, Bia Nisa Franco Fernandes
Publicado em: (2021)
por: Abreu, Bia Nisa Franco Fernandes
Publicado em: (2021)
article Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
por: Karkucinska-Wieckowska, Agnieszka
Publicado em: (2022)
por: Karkucinska-Wieckowska, Agnieszka
Publicado em: (2022)
article Utilidade da elastografia hepática transitória (FibroScan®) na cirrose hepática
por: Marinho,R.
Publicado em: (2007)
por: Marinho,R.
Publicado em: (2007)
article Bridging Critically Ill Patients With Cirrhosis to Transplant With Renal Replacement Therapy
por: Cardoso, Filipe S.
Publicado em: (2026)
por: Cardoso, Filipe S.
Publicado em: (2026)
article Differential alterations in mitochondrial function induced by a choline-deficient diet: Understanding fatty liver disease progression
por: Teodoro, João S.
Publicado em: (2008)
por: Teodoro, João S.
Publicado em: (2008)
article Decreased ANT content in Zucker fatty rats: Relevance for altered hepatic mitochondrial bioenergetics in steatosis
por: Teodoro, João
Publicado em: (2006)
por: Teodoro, João
Publicado em: (2006)
assignment Auxiliary Liver Transplantation as a Transient Treatment for Acute Liver Failure: Two Cases
por: Perdigoto,David N.
Publicado em: (2019)
por: Perdigoto,David N.
Publicado em: (2019)
assignment Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children
por: Dias,Catarina Leuzinger
Publicado em: (2019)
por: Dias,Catarina Leuzinger
Publicado em: (2019)
article Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
por: Sousa-Lima, Inês
Publicado em: (2021)
por: Sousa-Lima, Inês
Publicado em: (2021)
Registos relacionados
-
article Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease
por: Andrade,Patrícia
Publicado em: (2017) -
school Prevalence and risk factors for fatty liver post liver transplantation : a systematic review and meta analysis
por: Silva, Ana Carolina Morais da
Publicado em: (2022) -
assignment Acute fatty liver of pregnancy: case report
por: Vilela,Fernanda
Publicado em: (2017) -
article Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: challenges and opportunities
por: Silva, Barbara Sofia Marques da
Publicado em: (2025) -
article Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease
por: Gaspar,Rui
Publicado em: (2024)